HIGHLIGHTS
- who: Chanjuan Shi and Michael A. Morse from the Department of Pathology, Duke University Medical Center, Durham, NC, USA have published the paper: Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors, in the Journal: Cancers 2022, 14, 6114. of /2022/
- future: Future Directions Multikinase inhibitors with novel combinations of activities may be effective after or in place of existing TKIs.
SUMMARY
While debulking surgery and locoregional therapies are an option for some, in the majority, progressive disease eventually requires systemic therapy to control hormonal-driven syndromes for functional GEP-NETs and to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.